{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T03:32:08Z","timestamp":1773977528118,"version":"3.50.1"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009110","name":"Xinjiang Uygur Autonomous Region Natural Science Foundation","doi-asserted-by":"publisher","award":["2022D01C244"],"award-info":[{"award-number":["2022D01C244"]}],"id":[{"id":"10.13039\/100009110","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.mce.2026.112733","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T07:59:17Z","timestamp":1768291157000},"page":"112733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Hsp90\u03b1 as a promising therapeutic target for suppressing tumor progression in Lactotroph PitNETs"],"prefix":"10.1016","volume":"614","author":[{"given":"Jie","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chongxue","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingrong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2026.112733_bib1","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1210\/en.2007-1066","article-title":"Human prolactin gene promoter regulation by estrogen: convergence with tumor necrosis factor-alpha signaling","volume":"149","author":"Adamson","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2026.112733_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108846","article-title":"MMP-2 and MMP-9 mediate cigarette smoke extract-induced epithelial-mesenchymal transition in airway epithelial cells via EGFR\/Akt\/GSK3\u03b2\/\u03b2-catenin pathway: amelioration by fisetin","volume":"314","author":"Agraval","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.mce.2026.112733_bib3","doi-asserted-by":"crossref","first-page":"26879","DOI":"10.1074\/jbc.M113.492280","article-title":"Destabilization of the epidermal growth factor receptor (EGFR) by a peptide that inhibits EGFR binding to heat shock protein 90 and receptor dimerization","volume":"288","author":"Ahsan","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2026.112733_bib4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","article-title":"Overview of the 2022 WHO classification of pituitary tumors","volume":"33","author":"Asa","year":"2022","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.mce.2026.112733_bib6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrendo.2015.36","article-title":"New insights in prolactin: pathological implications","volume":"11","author":"Bernard","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.mce.2026.112733_bib7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1677\/joe.1.06368","article-title":"Prolactin activates mammalian target-of-rapamycin through phosphatidylinositol 3-kinase and stimulates phosphorylation of p70S6K and 4E-binding protein-1 in lymphoma cells","volume":"190","author":"Bishop","year":"2006","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.mce.2026.112733_bib8","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1210\/endo.130.6.1534540","article-title":"Dopamine receptor activation inhibits estrogen-stimulated transforming growth factor-alpha gene expression and growth in anterior pituitary, but not in uterus","volume":"130","author":"Borgundvaag","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2026.112733_bib9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41401-020-0398-2","article-title":"DCZ5248, a novel dual inhibitor of Hsp90 and autophagy, exerts antitumor activity against colon cancer","volume":"42","author":"Chen","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.mce.2026.112733_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157103","article-title":"Shanzhiside methyl ester attenuated cognitive impairment in diabetic mice by inhibiting neuroinflammation and glycolysis via HSP90AA1\/HIF1A\/STAT1","volume":"146","author":"Chen","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.mce.2026.112733_bib11","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1530\/EJE-21-0977","article-title":"Italian Association of Clinical Endocrinologists (AME) and International Chapter of Clinical Endocrinology (ICCE).Position statement for clinical practice: prolactin-secreting tumors","volume":"186","author":"Cozzi","year":"2022","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.mce.2026.112733_bib12","first-page":"1","article-title":"The ELISA guidebook","volume":"149","author":"Crowther","year":"2000","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.mce.2026.112733_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.860320","article-title":"Heat shock proteins and HSF1 in cancer","volume":"12","author":"Cyran","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.mce.2026.112733_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310952","article-title":"The role of activation of PI3K\/AKT\/mTOR and RAF\/MEK\/ERK pathways in aggressive pituitary adenomas-new potential therapeutic Approach-A systematic review","volume":"24","author":"Derwich","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mce.2026.112733_bib15","article-title":"Is prolactin receptor signaling a target in dopamine-resistant prolactinomas?","volume":"13","author":"Ferraris","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.mce.2026.112733_bib16","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S2213-8587(25)00227-X","article-title":"Prolactin-secreting adenomas: pathogenesis, diagnosis, and management","volume":"13","author":"Fleseriu","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.mce.2026.112733_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jsbmb.2005.01.018","article-title":"Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells","volume":"94","author":"Gougelet","year":"2005","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2026.112733_bib18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41392-025-02166-2","article-title":"Advances in the structures, mechanisms and targeting of molecular chaperones","volume":"10","author":"Gu","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.mce.2026.112733_bib19","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.jocn.2015.02.021","article-title":"Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-2: prognostic biological markers in invasive prolactinomas","volume":"22","author":"G\u00fcltekin","year":"2015","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.mce.2026.112733_bib20","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.2174\/1381612822666160325152200","article-title":"Current understanding of HSP90 as a novel therapeutic target: an emerging approach for the treatment of cancer","volume":"22","author":"Haque","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.mce.2026.112733_bib21","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/bmb.21552","article-title":"Real-time quantitative PCR: a tool for absolute and relative quantification","volume":"49","author":"Harshitha","year":"2021","journal-title":"Biochem. Mol. Biol. Educ."},{"key":"10.1016\/j.mce.2026.112733_bib22","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nature10317","article-title":"Molecular chaperones in protein folding and proteostasis","volume":"475","author":"Hartl","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.mce.2026.112733_bib23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature10912","article-title":"The translational landscape of mTOR signalling steers cancer initiation and metastasis","volume":"485","author":"Hsieh","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.mce.2026.112733_bib24","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1517\/13543784.2014.902442","article-title":"Heat shock protein 90 inhibitors in the treatment of cancer: current status and future directions","volume":"23","author":"Jhaveri","year":"2014","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.mce.2026.112733_bib25","series-title":"Cell Viability Assays: Methods and Protocols","article-title":"Transwell in vitro cell migration and invasion assays","author":"Justus","year":"2023"},{"key":"10.1016\/j.mce.2026.112733_bib26","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/978-1-0716-3052-5_22","article-title":"Transwell in vitro cell migration and invasion assays","volume":"2644","author":"Justus","year":"2023","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.mce.2026.112733_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ph18081083","article-title":"Combination strategies with HSP90 inhibitors in cancer therapy: mechanisms, challenges, and future perspectives","volume":"18","author":"Kim","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.mce.2026.112733_bib28","first-page":"610","article-title":"Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings","volume":"33","author":"Knosp","year":"1993","journal-title":"Neurosurgery"},{"key":"10.1016\/j.mce.2026.112733_bib29","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ymeth.2005.11.007","article-title":"Western blotting","volume":"38","author":"Kurien","year":"2006","journal-title":"Methods"},{"key":"10.1016\/j.mce.2026.112733_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2025.112598","article-title":"Aggressive pituitary tumours and pituitary carcinomas: molecular insights guiding management and the role of precision oncology","volume":"607","author":"Lamb","year":"2025","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2026.112733_bib31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","article-title":"mTOR at the nexus of nutrition, growth, ageing and disease","volume":"21","author":"Liu","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.mce.2026.112733_bib32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1210\/en.2014-1627","article-title":"ErbB receptor-driven prolactinomas respond to targeted lapatinib treatment in female transgenic mice","volume":"156","author":"Liu","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2026.112733_bib33","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1111\/cas.14143","article-title":"A novel pan-cancer biomarker plasma heat shock protein 90alpha and its diagnosis determinants in clinic","volume":"110","author":"Liu","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.mce.2026.112733_bib34","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3389\/fendo.2019.00785","article-title":"Expression of EGFR in pituitary corticotroph adenomas and its relationship with tumor behavior","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.mce.2026.112733_bib35","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/978-1-4939-8935-5_25","article-title":"An introduction to the performance of immunohistochemistry","volume":"1897","author":"Magaki","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.mce.2026.112733_bib36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1517\/14712598.2.1.3","article-title":"HSP90 as a new therapeutic target for cancer therapy: the story unfolds","volume":"2","author":"Maloney","year":"2002","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.mce.2026.112733_bib37","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","article-title":"AKT\/PKB signaling: navigating the network","volume":"169","author":"Manning","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.mce.2026.112733_bib38","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1056\/NEJMra1810772","article-title":"Pituitary-Tumor endocrinopathies","volume":"382","author":"Melmed","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2026.112733_bib39","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11102-008-0106-6","article-title":"Drugs and prolactin","volume":"11","author":"Molitch","year":"2008","journal-title":"Pituitary"},{"key":"10.1016\/j.mce.2026.112733_bib40","first-page":"10","article-title":"Relationship between (18)F-FDG uptake and heat shock protein 90\u03b1 expression in colorectal cancer","volume":"24","author":"Nam","year":"2021","journal-title":"Hellenic J. Nucl. Med."},{"key":"10.1016\/j.mce.2026.112733_bib41","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1158\/1078-0432.CCR-11-1000","article-title":"Hsp90 molecular chaperone inhibitors: are we there yet?","volume":"18","author":"Neckers","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mce.2026.112733_bib42","article-title":"Targeting HSP90 inhibits proliferation and induces apoptosis through AKT1\/ERK pathway in lung cancer","volume":"12","author":"Niu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.mce.2026.112733_bib43","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/modpathol.3800118","article-title":"Analysis of epidermal growth factor receptor and activated epidermal growth factor receptor expression in pituitary adenomas and carcinomas","volume":"17","author":"Onguru","year":"2004","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.mce.2026.112733_bib44","series-title":"The Pituitary","article-title":"Chapter 5 - prolactin","author":"Paragliola","year":"2022"},{"key":"10.1016\/j.mce.2026.112733_bib45","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1517\/17460441.2011.563296","article-title":"Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment","volume":"6","author":"Patel","year":"2011","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.mce.2026.112733_bib46","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","article-title":"Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement","volume":"19","author":"Petersenn","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.mce.2026.112733_bib47","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-17-0796","article-title":"European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas","volume":"178","author":"Raverot","year":"2018","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.mce.2026.112733_bib48","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1093\/ejendo\/lvaf100","article-title":"Revised European Society of Endocrinology Clinical Practice Guideline for the management of aggressive pituitary tumours and pituitary carcinomas","volume":"192","author":"Raverot","year":"2025","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.mce.2026.112733_bib49","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.3390\/cells11162556","article-title":"Targeting heat-shock protein 90 in cancer: an update on combination therapy","volume":"11","author":"Ren","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.mce.2026.112733_bib50","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.phrs.2012.04.005","article-title":"ERK1\/2 MAP kinases: structure, function, and regulation","volume":"66","author":"Roskoski","year":"2012","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.mce.2026.112733_bib51","first-page":"10832","volume":"vol. 97","author":"Sato","year":"2000"},{"key":"10.1016\/j.mce.2026.112733_bib52","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrm.2017.20","article-title":"The HSP90 chaperone machinery","volume":"18","author":"Schopf","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.mce.2026.112733_bib53","doi-asserted-by":"crossref","DOI":"10.1177\/11779322231224187","article-title":"Revealing propolis potential activity on inhibiting estrogen receptor and heat shock protein 90 overexpressed in breast cancer by bioinformatics approaches","volume":"18","author":"Simanjuntak","year":"2024","journal-title":"Bioinf. Biol. Insights"},{"key":"10.1016\/j.mce.2026.112733_bib54","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0014-5793(04)00229-7","article-title":"Hsp90 isoforms: functions, expression and clinical importance","volume":"562","author":"Sreedhar","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.mce.2026.112733_bib55","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.4161\/cc.9.8.11487","article-title":"Dominant roles of the Raf\/MEK\/ERK pathway in cell cycle progression, prevention of apoptosis and sensitivity to chemotherapeutic drugs","volume":"9","author":"Steelman","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.mce.2026.112733_bib56","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrm2918","article-title":"HSP90 at the hub of protein homeostasis: emerging mechanistic insights","volume":"11","author":"Taipale","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.mce.2026.112733_bib57","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.mce.2026.112733_bib58","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature11083","article-title":"A unifying model for mTORC1-mediated regulation of mRNA translation","volume":"485","author":"Thoreen","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.mce.2026.112733_bib59","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1556\/650.2023.32832","article-title":"[Aggressive pituitary adenoma and pituitary carcinoma]","volume":"164","author":"T\u00f3th","year":"2023","journal-title":"Orv. Hetil."},{"key":"10.1016\/j.mce.2026.112733_bib60","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrc2887","article-title":"Targeting the dynamic HSP90 complex in cancer","volume":"10","author":"Trepel","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mce.2026.112733_bib61","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00428-019-02655-0","article-title":"A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal","volume":"475","author":"Villa","year":"2019","journal-title":"Virchows Arch."},{"key":"10.1016\/j.mce.2026.112733_bib62","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3390\/jcm11010124","article-title":"Targeting aggressive pituitary adenomas at the molecular level\u2014a review","volume":"11","author":"Voellger","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.mce.2026.112733_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9050052","article-title":"Epidermal growth factor receptor cell proliferation signaling pathways","volume":"9","author":"Wee","year":"2017","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mce.2026.112733_bib64","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nrc1716","article-title":"HSP90 and the chaperoning of cancer","volume":"5","author":"Whitesell","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mce.2026.112733_bib65","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.canlet.2003.08.032","article-title":"Combinatorial attack on multistep oncogenesis by inhibiting the Hsp90 molecular chaperone","volume":"206","author":"Workman","year":"2004","journal-title":"Cancer Lett."},{"key":"10.1016\/j.mce.2026.112733_bib66","first-page":"2920","article-title":"ESM1 promotes angiogenesis in colorectal cancer by activating PI3K\/Akt\/mTOR pathway, thus accelerating tumor progression","volume":"15","author":"Yang","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.mce.2026.112733_bib67","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/s41422-022-00736-5","article-title":"Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumors","volume":"32","author":"Zhang","year":"2022","journal-title":"Cell Res."},{"key":"10.1016\/j.mce.2026.112733_bib68","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1530\/ERC-22-0168","article-title":"TLR4 inhibition suppresses growth in oestrogen-induced prolactinoma models","volume":"29","author":"Zhang","year":"2022","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.mce.2026.112733_bib69","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.3748\/wjg.v9.i11.2616","article-title":"Significance of expression of heat shock protein90alpha in human gastric cancer","volume":"9","author":"Zuo","year":"2003","journal-title":"World J. Gastroenterol."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720726000109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720726000109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T02:29:28Z","timestamp":1773973768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720726000109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":68,"alternative-id":["S0303720726000109"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2026.112733","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hsp90\u03b1 as a promising therapeutic target for suppressing tumor progression in Lactotroph PitNETs","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2026.112733","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112733"}}